Interleukin-1 beta (IL-1β) is a proinflammatory cytokine primarily produced by activated macrophages, as well as neutrophils, epithelial cells, and endothelial cells. It plays a central role in immune ...

Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome ...

DENVER — New analyses of results from the first-line options for systemic juvenile idiopathic arthritis (sJIA) treatment (FROST) study revealed insights into long-term outcomes of treatment with ...

Interleukin 6 receptor (IL-6r) inhibition is a promising approach for the treatment of calcium pyrophosphate deposition disease (CPPD), although no prospective studies have been conducted to date.